Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding the impact of climate change on mental health from a Canadian perspective: a scoping review.

Health promotion and chronic disease prevention in Canada : research, policy and practice·2026
Same author

Job strain and ischemic heart disease: the balance of methodological bias and implications for prevention. Response to: Bonde JP et al. The demands-control-support work stress model and risk of ischemic heart disease: causal inference based on observational epidemiology.

Scandinavian journal of work, environment & health·2026
Same author

2024/25 end-of-season KP.2 vaccine effectiveness against COVID-19 hospitalization in older adults: a test-negative study in Quebec, Canada.

Vaccine·2026
Same author

Heatwrap and exercise in acute low back pain: a multi-arm randomised controlled trial.

Musculoskeletal science & practice·2026
Same author

Nirsevimab effectiveness, number needed to immunize and impact on severe RSV outcomes, a test-negative study in Quebec, Canada.

Lancet regional health. Americas·2026
Same author

Validation of PREM-PS, a patient-reported experience instrument, in a randomized controlled trial of pregnant women undergoing prenatal screening.

Journal of patient-reported outcomes·2026

Related Experiment Videos

Initial Cardiovascular Disease Risk Assessment in Nonclinical Settings: Framingham-Simplified Model Predictive

Jacquecin Garçon1,2, Mathilde Lavigne-Robichaud2, Alain Milot2,3

  • 1Department of Social and Preventive Medicine, Faculty of Medicine, Université Laval, Québec, Québec, Canada.

CJC Open
|June 22, 2026
PubMed
Summary

The Framingham-SP model shows acceptable cardiovascular disease (CVD) risk prediction in Canada. This simplified tool aids preliminary CVD risk assessment and lifestyle counseling, especially in nonclinical settings.

Keywords:
Framingham, non-laboratory basedcardiovascular diseasecohort study, nonclinical settingsexternal validation studyrisk prediction

Related Experiment Videos

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • The Framingham risk model is standard for estimating 10-year cardiovascular disease (CVD) risk in Canada.
  • The simplified Framingham-SP model uses body mass index instead of lipids, reducing the need for lab tests.
  • The predictive accuracy of Framingham-SP in a Canadian population was previously unestablished.

Purpose of the Study:

  • To externally validate the predictive performance of the Framingham-SP model.
  • To assess the discrimination and calibration of the Framingham-SP model in a prospective Canadian cohort.
  • To determine the model's utility for preliminary cardiovascular risk assessment.

Main Methods:

  • A prospective cohort study included 7363 participants (3692 women, 3671 men) free of CVD at baseline (1999-2001).
  • Incident CVD events were tracked via medico-administrative databases until 2011.
  • Model discrimination was assessed using C-statistics, and calibration was evaluated using calibration-in-the-large, absolute difference, and discordance.

Main Results:

  • Over 10 years, 211 CVD events occurred in women and 453 in men.
  • For women, predicted risk was 4.07% (observed 5.72%), C-statistic 0.72; for men, predicted risk was 11.73% (observed 12.34%), C-statistic 0.72.
  • Calibration was less accurate for women, particularly in intermediate and high predicted risk categories.

Conclusions:

  • The Framingham-SP model demonstrated acceptable predictive performance in this Canadian cohort.
  • Its simplified nature supports preliminary CVD risk assessment and lifestyle counseling, complementing clinical evaluations.
  • Recalibration of the model may enhance its predictive accuracy for high-risk women.